Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 04/04/2024, 18:21
Updated 04/04/2024, 19:41
© Reuters.  Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.

STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies.
  • Allurion Technologies Inc. (NASDAQ: ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target.
  • Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development.
  • HWH International Inc. (NASDAQ: HWH) gained 38.8% to $2.1765.
  • Candel Therapeutics, Inc. (NASDAQ: CADL) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer.
  • MacroGenics, Inc. (NASDAQ: MGNX) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting.
  • E-Home Household Service Holdings Limited (NASDAQ: EJH) gained 27% to $2.22.
  • Reliance Global Group, Inc. (NASDAQ: RELI) gained 24.6% to $0.46 after the company reported FY23 earnings.
  • Simulations Plus, Inc. (NASDAQ: SLP) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter.
  • Vast Renewables Limited (NASDAQ: VSTE) gained 22.3% to $8.81.
  • Sportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss.
  • Gorilla Technology Group Inc. (NASDAQ: GRRR) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results.
  • Levi Strauss & Co. (NYSE: LEVI) shares rose 18.3% to $22.10 after the company reported upbeat earnings for its first quarter and boosted its 2024 earnings guidance.
  • NOVONIX Limited (NYSE: NVX) gained 15.4% to $2.83.
  • Zeta Global Holdings Corp. (NYSE: ZETA) climbed 14.8% to $12.09 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $17.
  • Graphjet Technology (NASDAQ: GTI) gained 13.3% to $8.17
  • MaxLinear, Inc. (NASDAQ: MXL) gained 11.8% to $24.22. MaxLinear is expected to release its financial results for the first quarter 2024 after the closing bell on April 24, 2024.
  • Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) gained 9.7% to $1.81. Eiger Biopharmaceuticals said on April 2, it received a notice from the Nasdaq that the company’s common stock will be delisted from Nasdaq.
  • Destiny Tech100 Inc. (NASDAQ: DXYZ) shares gained 8.8% to $29.39 after jumping 27% on Wednesday.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) shares rose 8.2% to $16.76. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix..
  • MicroStrategy Incorporated (NASDAQ: MSTR) gained 7.4% to $1,724.42 amid a rise in Bitcoin.
  • Enphase Energy, Inc. (NASDAQ: ENPH) climbed 7% to $126.86.
  • HubSpot, Inc. (NYSE: HUBS) gained 6% to $664.51 following a report suggesting Alphabet is in talks with advisors about a potential offer for the company.
  • BlackBerry Limited (NYSE: BB) climbed 4% to $2.9223 after the company reported fourth-quarter results and issued FY25 guidance.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares dipped 80.7% to $3.1801. The company announced topline results from the primary analysis of the randomized Phase 2 KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer.
  • Keyarch Acquisition Corporation (NASDAQ: KYCH) fell 34.5% to $5.94.
  • View, Inc. (NASDAQ: VIEW) fell 29.4% to $0.3601. View shares fell on Wednesday after the company filed for Chapter 11 bankruptcy.
  • Achilles Therapeutics plc (NASDAQ: ACHL) declined 27% to $0.88 after the company reported fourth-quarter financial results. The company announced interim Phase I/IIa data on the use of clonal neoantigen reactive T cells from the CHIRON study in advanced unresectable or metastatic non-small cell lung cancer and the THETIS study in recurrent or metastatic malignant melanoma.
  • KWESST Micro Systems Inc. (NASDAQ: KWE) fell 24.4% to $0.85 after the company announced a proposed US public offering.
  • AXT, Inc. (NASDAQ: AXTI) fell 22.2% to $3.85. Traders circulated J Capital short report.
  • XTI Aerospace, Inc. (NASDAQ: XTIA) fell 20.9% to $3.64 after gaining 31% on Wednesday.
  • DigiAsia Corp. (NASDAQ: FAAS) fell 20% to $5.37.
  • Lamb Weston Holdings, Inc. (NYSE: LW) declined 17.5% to $83.40 after the company reported weak third-quarter results and cut its FY24 outlook.
  • Selina Hospitality PLC (NASDAQ: SLNA) dipped 17.5% to $0.0811.
  • Casa Systems, Inc. (NASDAQ: CASA) declined 16.3% to $0.0460. Casa Systems said the company and some units entered into asset purchase agreement with Lumine providing for sale and purchase of debtors' Cloud/Ran APA assets.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) fell 15.2% to $0.1390. Kintara Therapeutics recently entered a merger agreement with TuHURA Biosciences.
  • Flora Growth Corp. (NASDAQ: FLGC) fell 13.5% to $2.3095 after the company reported the launch of proposed underwritten public offering of common shares.
  • GCT Semiconductor Holding, Inc. (NYSE: GCTS) fell 13.1% to $5.96.
  • SolarMax Technology, Inc. (NASDAQ: SMXT) dipped 10.9% to $11.75.
  • LAMF Global Ventures Corp. I (NASDAQ: LGVC) shares tumbled 10.2% to $9.97. LAMF Global Ventures Corp. I shares gained 3% on Wednesday after the company announced shareholders approved the previously announced business combination with Nuvo.
  • ARCA biopharma, Inc. (NASDAQ: ABIO) fell 8.9% to $2.96. ARCA Biopharma shares jumped 90% on Wednesday after the company and Oruka Therapeutics announced a merger agreement.
  • Aquestive Therapeutics, Inc. (NASDAQ: AQST) fell 8.9% to $3.9850 after the company filed for an up to $250 million mixed shelf offering.
  • OneMedNet Corporation (NASDAQ: ONMD) shares fell 8.6% to $0.97. OneMedNet shares jumped 34% on Wednesday after the company completed a securities purchase agreement to provide up to $4.54 million in funding.
  • Rent the Runway, Inc. (NASDAQ: RENT) fell 8.6% to $5.37.
  • Paramount Global (NASDAQ: PARA) fell 8.2% to $12.40 following a report suggesting the Ellison-led bid would require the company to raise new equity.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Bitcoin Tops $66,000 Following Jobless Claims Data; Ethena Emerges As Top Gainer

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.